Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Pediatric Medicines Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Enteral
  • 1.3.3 Parenteral
  • 1.3.4 Topical
• 1.4 Market Segment by Application
  • 1.4.1 Global Pediatric Medicines Market Share by Application (2019-2025)
  • 1.4.2 Hospital
  • 1.4.3 Clinic
  • 1.4.4 Family
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Pediatric Medicines Market Size
  • 2.1.1 Global Pediatric Medicines Revenue 2014-2025
  • 2.1.2 Global Pediatric Medicines Sales 2014-2025
• 2.2 Pediatric Medicines Growth Rate by Regions
  • 2.2.1 Global Pediatric Medicines Sales by Regions 2014-2019
  • 2.2.2 Global Pediatric Medicines Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Pediatric Medicines Sales by Manufacturers
  • 3.1.1 Pediatric Medicines Sales by Manufacturers 2014-2019
  • 3.1.2 Pediatric Medicines Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Pediatric Medicines Revenue by Manufacturers (2014-2019)
  • 3.2.2 Pediatric Medicines Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Pediatric Medicines Market Concentration Ratio (CR5 and HHI)
• 3.3 Pediatric Medicines Price by Manufacturers
• 3.4 Key Manufacturers Pediatric Medicines Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Pediatric Medicines Market
• 3.6 Key Manufacturers Pediatric Medicines Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Enteral Sales and Revenue (2014-2019)
  • 4.1.2 Parenteral Sales and Revenue (2014-2019)
  • 4.1.3 Topical Sales and Revenue (2014-2019)
• 4.2 Global Pediatric Medicines Sales Market Share by Type
• 4.3 Global Pediatric Medicines Revenue Market Share by Type
• 4.4 Pediatric Medicines Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Pediatric Medicines Sales by Application

6 United States

• 6.1 United States Pediatric Medicines Breakdown Data by Company
• 6.2 United States Pediatric Medicines Breakdown Data by Type
• 6.3 United States Pediatric Medicines Breakdown Data by Application

7 European Union

• 7.1 European Union Pediatric Medicines Breakdown Data by Company
• 7.2 European Union Pediatric Medicines Breakdown Data by Type
• 7.3 European Union Pediatric Medicines Breakdown Data by Application

8 China

• 8.1 China Pediatric Medicines Breakdown Data by Company
• 8.2 China Pediatric Medicines Breakdown Data by Type
• 8.3 China Pediatric Medicines Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Pediatric Medicines Breakdown Data by Company
• 9.2 Rest of World Pediatric Medicines Breakdown Data by Type
• 9.3 Rest of World Pediatric Medicines Breakdown Data by Application
• 9.4 Rest of World Pediatric Medicines Breakdown Data by Countries
  • 9.4.1 Rest of World Pediatric Medicines Sales by Countries
  • 9.4.2 Rest of World Pediatric Medicines Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 GSK
  • 10.1.1 GSK Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Pediatric Medicines
  • 10.1.4 Pediatric Medicines Product Introduction
  • 10.1.5 GSK Recent Development
• 10.2 Novartis
  • 10.2.1 Novartis Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Pediatric Medicines
  • 10.2.4 Pediatric Medicines Product Introduction
  • 10.2.5 Novartis Recent Development
• 10.3 Pfizer
  • 10.3.1 Pfizer Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Pediatric Medicines
  • 10.3.4 Pediatric Medicines Product Introduction
  • 10.3.5 Pfizer Recent Development
• 10.4 Sanofi
  • 10.4.1 Sanofi Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Pediatric Medicines
  • 10.4.4 Pediatric Medicines Product Introduction
  • 10.4.5 Sanofi Recent Development
• 10.5 Abbott
  • 10.5.1 Abbott Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Pediatric Medicines
  • 10.5.4 Pediatric Medicines Product Introduction
  • 10.5.5 Abbott Recent Development
• 10.6 Bristol-Myers Squibb
  • 10.6.1 Bristol-Myers Squibb Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Pediatric Medicines
  • 10.6.4 Pediatric Medicines Product Introduction
  • 10.6.5 Bristol-Myers Squibb Recent Development
• 10.7 Cipla
  • 10.7.1 Cipla Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Pediatric Medicines
  • 10.7.4 Pediatric Medicines Product Introduction
  • 10.7.5 Cipla Recent Development
• 10.8 Eisai Pharmaceuticals
  • 10.8.1 Eisai Pharmaceuticals Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Pediatric Medicines
  • 10.8.4 Pediatric Medicines Product Introduction
  • 10.8.5 Eisai Pharmaceuticals Recent Development
• 10.9 Eli Lilly
  • 10.9.1 Eli Lilly Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Pediatric Medicines
  • 10.9.4 Pediatric Medicines Product Introduction
  • 10.9.5 Eli Lilly Recent Development
• 10.10 F. Hoffman-La Roche
  • 10.10.1 F. Hoffman-La Roche Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Pediatric Medicines
  • 10.10.4 Pediatric Medicines Product Introduction
  • 10.10.5 F. Hoffman-La Roche Recent Development
• 10.11 Glenmark
• 10.12 Helsinn Healthcare
• 10.13 Heron Therapeutics
• 10.14 Ipca Laboratories

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Pediatric Medicines Sales Channels
  • 11.2.2 Pediatric Medicines Distributors
• 11.3 Pediatric Medicines Customers

12 Market Forecast

• 12.1 Global Pediatric Medicines Sales and Revenue Forecast 2019-2025
• 12.2 Global Pediatric Medicines Sales Forecast by Type
• 12.3 Global Pediatric Medicines Sales Forecast by Application
• 12.4 Pediatric Medicines Forecast by Regions
  • 12.4.1 Global Pediatric Medicines Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Pediatric Medicines Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

The pediatric drug market plays a pivotal role in the pharmaceutical industry.
The pediatric medicines market identifies the formulatory advancement as one of the primary factors for this market’s growth.
In 2019, the market size of Pediatric Medicines is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Pediatric Medicines.

This report studies the global market size of Pediatric Medicines, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Pediatric Medicines sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
GSK
Novartis
Pfizer
Sanofi
Abbott
Bristol-Myers Squibb
Cipla
Eisai Pharmaceuticals
Eli Lilly
F. Hoffman-La Roche
Glenmark
Helsinn Healthcare
Heron Therapeutics
Ipca Laboratories

Market Segment by Product Type
Enteral
Parenteral
Topical

Market Segment by Application
Hospital
Clinic
Family

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Pediatric Medicines status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Pediatric Medicines manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Pediatric Medicines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025